Greek English

Contracted laboratory for Biomarkers

BIOANALYTICA GENOTYPE SA was established in December 2004 as a biotech startup aiming to provide specialised molecular cytogenetic research and application services to the biomedical Community.

 

Was funded by BIOANALYTICA SA, a leading stakeholder in the greek market for molecular diagnostics and laboratory infrastructure, and by the researcher Dr. Georgia Bardi, Associate Professor of Experimental Clinical Genetics at the Medical school of Lund University, Sweden and former Director of the Cytogenetics facility at Saint Savas Oncology hospital of Athens.

 

Is co-financed by the Greek General Secretariat of Research and Technology under the 3rd Community Support Program (03 Praxe 26).

 

 

Links

Σύνδεσμοι

ifhgs

European Society of Human Genetics

www.eshg.org

ifhgs

International Federation of Human Genetics Societies

www.ifhgs.org

genetests

GeneTests portal

www.ncbi.nlm.nih.gov/sites/GeneTests

pev logo

Hellenic Society of BioScientists

www.pev.gr

bioethics2 National Bioethics Commission

www.bioethics.gr

eae Hellenic Society of Haematology www.eae.gr
hsmo Hellenic Society of Medical Oncology

www.hesmo.gr

esyd

Hellenic Accreditation System

www.esyd.gr
sbba logo

SafeBlood BioAnalytica SA

www.sbbio.gr

orphanet Orpha Net

www.orpha.net

eca

European Cytogenetics Association

www.e-c-a.eu

emqn European Molecular Genetics Quality Network

www.emqn.org

ukneqas

United Kingdom National External Quality Assessment Service

www.ukneqas.org.uk

BioAnalytica-Genotype SA serves the healthcare market by offering Cytogenetics and Molecular Genetics tests, designed to answer questions related to diagnosis, prognosis and therapy selection for hematologic and solid tumor cancers.